Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

Literature DB >> 23281122

A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

Haijun Chen¹, Cheng Z Wang, Chunyong Ding, Christopher Wild, Bryan Copits, Geoffrey T Swanson, Kenneth M Johnson, Jia Zhou.

Abstract

PAMs new in town! An effective, combined bioinformatics and chemoinformatics approach was applied to the design of novel asymmetric bivalent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor positive allosteric modulators (PAMs) with marked potency in vitro and efficacy in vivo for preventing neuroapoptosis. The novel chemotype could provide pharmacological probes and potential therapeutic agents for glutamatergic hypofunction and its related neurological and psychiatric disorders.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23281122 PMCID： PMC3733225 DOI： 10.1002/cmdc.201200554

Source DB: PubMed Journal: ChemMedChem ISSN： 1860-7179 Impact factor: 3.466

53 in total

1. Rational drug discovery revisited: interfacing experimental programs with bio- and chemo-informatics.

Authors: J Bajorath
Journal: Drug Discov Today Date: 2001-10-01 Impact factor: 7.851

2. The Protein Data Bank at 40: reflecting on the past to prepare for the future.

Authors: Helen M Berman; Gerard J Kleywegt; Haruki Nakamura; John L Markley
Journal: Structure Date: 2012-03-07 Impact factor: 5.006

Review 3. Glutamate receptor ion channels: structure, regulation, and function.

Authors: Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal: Pharmacol Rev Date: 2010-09 Impact factor: 25.468

Review 4. Challenges for and current status of research into positive modulators of AMPA receptors.

Authors: Simon E Ward; Benjamin D Bax; Mark Harries
Journal: Br J Pharmacol Date: 2010-05 Impact factor: 8.739

5. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors: Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal: ACS Chem Neurosci Date: 2010-03-25 Impact factor: 4.418

6. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.

Authors: James H Nettles; Jeremy L Jenkins; Andreas Bender; Zhan Deng; John W Davies; Meir Glick
Journal: J Med Chem Date: 2006-11-16 Impact factor: 7.446

7. Ampakines and the threefold path to cognitive enhancement.

Authors: Gary Lynch; Christine M Gall
Journal: Trends Neurosci Date: 2006-08-07 Impact factor: 13.837

8. Role of caspase-3 in ethanol-induced developmental neurodegeneration.

Authors: Chainllie Young; Kevin A Roth; Barbara J Klocke; Tim West; David M Holtzman; Joann Labruyere; Yue-Qin Qin; Krikor Dikranian; John W Olney
Journal: Neurobiol Dis Date: 2005-05-31 Impact factor: 5.996

9. 5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors.

Authors: Umberto M Battisti; Krzysztof Jozwiak; Giuseppe Cannazza; Giulia Puia; Gabriella Stocca; Daniela Braghiroli; Carlo Parenti; Livio Brasili; Marina M Carrozzo; Cinzia Citti; Luigino Troisi
Journal: ACS Med Chem Lett Date: 2011-11-14 Impact factor: 4.345

10. New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.

Authors: Pierre Francotte; Eric Goffin; Pierre Fraikin; Pierre Lestage; Jean-Claude Van Heugen; Florian Gillotin; Laurence Danober; Jean-Yves Thomas; Patrice Chiap; Daniel-Henri Caignard; Bernard Pirotte; Pascal de Tullio
Journal: J Med Chem Date: 2010-02-25 Impact factor: 7.446

14 in total

Review 1. Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

Authors: Haijun Chen; Xiaobin Zhou; Ailan Wang; Yunquan Zheng; Yu Gao; Jia Zhou
Journal: Drug Discov Today Date: 2014-09-27 Impact factor: 7.851

2. Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).

Authors: Haijun Chen; Zhengduo Yang; Chunyong Ding; Ailian Xiong; Christopher Wild; Lili Wang; Na Ye; Guoshuai Cai; Rudolfo M Flores; Ye Ding; Qiang Shen; Jia Zhou
Journal: Eur J Med Chem Date: 2014-05-22 Impact factor: 6.514

Review 3. Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

Authors: Haijun Chen; Christopher Wild; Xiaobin Zhou; Na Ye; Xiaodong Cheng; Jia Zhou
Journal: J Med Chem Date: 2013-11-27 Impact factor: 7.446

A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

1. Rational drug discovery revisited: interfacing experimental programs with bio- and chemo-informatics.

2. The Protein Data Bank at 40: reflecting on the past to prepare for the future.

Review 3. Glutamate receptor ion channels: structure, regulation, and function.

Review 4. Challenges for and current status of research into positive modulators of AMPA receptors.

5. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

6. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.

7. Ampakines and the threefold path to cognitive enhancement.

8. Role of caspase-3 in ethanol-induced developmental neurodegeneration.

9. 5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors.

10. New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.

Review 1. Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

2. Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).

Review 3. Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

Review 4. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

5. AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.

Review 6. Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Review 7. Discovery and development of natural product oridonin-inspired anticancer agents.

Review 8. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

9. Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.

10. Small molecule inhibitors targeting activator protein 1 (AP-1).